Ondine Biomedical Inc. (formerly Ondine Biopharma Corporation) is dedicated to the development of non-antibiotic anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections. The Company is focused on the development and commercialization of its patented light activated technology, Photodisinfection (PDD), for multiple applications. PDD provides antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. Ondine Biomedical Inc. launched is first PDD product Periowaveâ„¢ in 2006. Periowaveâ„¢ is used as an adjunctive therapy for the treatment of chronic adult periodontitis (gum disease). In June 2009 Ondine sold its Dental Healthcare Business to PDT Inc.
Advanced Photodynamic Technologies, Inc. engages in research and development of photodynamic drugs and devices for antimicrobial and oncotherapeutic applications. The company has developed devices used for reduction of ventilator-associated pneumonia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.